Recently, it has even been demonstrated that alteration of the flanking sequence preferences of DNMT3A provides a key mechanistic basis for cancer promoting effects of the somatic DNMT3A R882H mutation, which is frequently observed in acute myeloid leukemia (AML)23,24. This evidence concerns the gene DNMT3A and acute myeloid leukemia.